RGT 4.92% 29.0¢ argent biopharma limited

It is difficult to see why a trading halt was called for this...

  1. 18 Posts.
    lightbulb Created with Sketch. 18
    It is difficult to see why a trading halt was called for this announcement. The executive has seen fit to use the mechanism of a trading halt, no doubt to influence and upramp share price to announce.....nothing. Unless I'm missing something, the binding agreement is for the "potential sales and distribution" precedent on "results delivered during the Trial indicating health-promoting effects" after "extensive market research by KS KIM to indicate demand and marketability". None of these even warrant an announcement as nothing of substance has actually happened yet. Ensuring that you have successful conduits to market at the completion of a trial is simply doing the job for which you are paid, there is no need for a song and dance act.

    Clearly those in charge of MXC are avid followers of Seinfeld who managed to make a successful series about nothing. Works for television but isn't the sound basis for running a commercial enterprise. The ASX is not twitter, stick to running the company not announcing the minutiae of daily business.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
(20min delay)
Last
29.0¢
Change
-0.015(4.92%)
Mkt cap ! $13.31M
Open High Low Value Volume
30.5¢ 30.5¢ 28.0¢ $29.96K 99.78K

Buyers (Bids)

No. Vol. Price($)
2 3379 28.5¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 3460 1
View Market Depth
Last trade - 15.37pm 16/07/2024 (20 minute delay) ?
RGT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.